Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001104659-25-101616·Rani Therapeutics Holdings, Inc.
Schedule 13D ownership disclosure
RANI THERAPEUTICS HLDGS INC
Class A Common Stock, par value $0.0001 per share · CUSIP: 753018100
Event date: 2025-10-20
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- South Cone Investments Limited PartnershipReported CIK 0001876412
Shares: 2,379,194.00 · Class: 4.9%
- South Lake One LLCReported CIK 0001794292
Shares: 2,379,194.00 · Class: 4.9%
- South Lake Management LLC
Shares: 2,379,194.00 · Class: 4.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-101616
- Form type
- SCHEDULE 13D/A
- Filer
- Rani Therapeutics Holdings, Inc.
- CIK
- CIK 1856725
- Filed
- Oct 22, 2025
- Reporting period
- Oct 20, 2025
- Description
- Schedule 13D beneficial ownership